Column GROUP Ii, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 5,378 shares at $4.95 ($27K) on 2023-01-12, disclosed to the SEC on 2023-01-17.
Open-market purchase of $27k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2019-10-21 | $1.4M | — | Filing → |
| NGM | BUY | 2019-08-09 | $3.1M | — | Filing → |
| NGM | BUY | 2019-05-13 | $496K | — | Filing → |